Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Vishwanatha, Jamboor K ^a   Salazar, Eric ^b   Gopalakrishnan, Velliyur K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b ST MARY'S UNIVERSITY   (United States)

Author keywords

Annexin I; Gene expression; Immunohistochemistry; Methylation; Oxidative stress

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CALCIUM BINDING PROTEIN; HYDROGEN PEROXIDE; LIPOCORTIN 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHOLIPID BINDING PROTEIN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DEMETHYLATION; ESOPHAGUS CANCER; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; NONHODGKIN LYMPHOMA; OXIDATIVE STRESS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN METHYLATION; RAJI CELL; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; DNA METHYLATION; GENETICS; METABOLISM; TUMOR CELL LINE;

ANNEXIN A1; CELL LINE, TUMOR; DNA METHYLATION; HUMANS; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDES; LYMPHOMA, B-CELL; NEOPLASM PROTEINS; RNA, MESSENGER;

EID: 3042755042     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-8     Document Type: Article

References (33)

1. Wallner BP, Mattaliano RJ, Hession C, Cate RL, Tizard R, Sinclair LK, Foeller C, Chow EP, Browing JL, Ramachandran KL, et al: Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 1986, 320:77-81.
2. Pepinsky RB, Sinclair LK: Epidermal growth factor-dependent phosphorylation of lipocortin. Nature 1986, 321:81-84.
3. Frey BM, Reber BF, Vishwanath BS, Escher G, Frey FJ: Annexin I modulates cell functions by controlling intracellular calcium release. FASEB J 1999, 13:2235-2245.
4. Skouteris GG, Schroder CH: The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor. J Biol Chem 1996, 271:27266-73.
5. Ernst JD, Hoye E, Blackwood RA, Mok TL: Identification of a domain that mediates vesicle aggregation reveals functional diversity of annexin repeats. Journal of Biological Chemistry 1991, 266:6670-6673.
6. Goulding NJ, Guyre PM: Glucocorticoids, lipocortins and the immune response. Current Opinion in Immunology 1993, 5:108-113.
7. Croxtall JD, Choudhury Q, Flower RJ: Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 2000, 130:289-298.
8. Alldridge LC, Harris HJ, Plevin R, Hannon R, Bryant CE: The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J Biol Chem 1999, 274:37620-37628.
9. Vishwanatha JK, Muns G, Beckmann JD, Davis RG, Rubinstein I: Differential expression of annexins I and II in bovine bronchial epithelial cells. American Journal of Respiratory Cell and Molecular Biology 1995, 12:280-286.
10. Smith SF, Tetley TD, Guz A, Flower RJ: Detection of lipocortin 1 in human lung lavage fluid: lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation. Environ Health Perspect 1990, 85:135-144.
11. Vishwanatha JK, Davis RG, Rubinstein I, Floreani A: Annexin I degradation in bronchoalveolar lavage fluids from healthy smokers: a possible mechanism of inflammation. Clin Cancer Res 1998, 4:2559-2564.
12. McKanna JA: Lipocortin 1 in apoptosis: Mammary regression. Anatomical Record 1995, 242:1-10.
13. Sakamoto T, Repasky WT, Uchida K, Hirata A, Hirata F: Modulation of cell death pathways to apoptosis and necrosis of H2O2-treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun 1996, 220:643-647.
14. Solito E, de Coupade C, Canaider S, Goulding NJ, Perretti M: Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001, 133:217-228.
15. Rothwell NJ, Flower R: Lipocortin-1 exhibits novel actions, providing clinical opportunities. Trends in Pharmacological Sciences 1992, 13:45-46.
16. Kumble KD, Hirota M, Pour PM, Vishwanatha JK: Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. Cancer Research 1992, 52:163-167.
17. Ahn SH, Sawada H, Ro JY, Nicolson GL: Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis 1997, 15:151-156.
18. Cole KA, Krizman DB, Emmert-Buck MR: The genetics of cancer- a 3D model. Nat Genet 1999, 21:38-41.
19. Zhi H, Zhang J, Hu G, Lu J, Wang X, Zhou C, Wu M, Liu Z: The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int J Cancer 2003, 106:327-333.
20. Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK: Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 2002, 8:117-123.
21. Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Linehan WM, Taylor PR, Liotta LA, Emmert-Buck MR, Petricoin EF,III: Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000, 60:6293-6297.
22. Chiang Y, Davis RG, Vishwanatha JK: Altered expression of annexin II in human B-cell lymphoma cell lines. Biochim Biophys Acta 1996, 1313:295-301.
23. Chetcuti A, Margan SH, Russell P, Mann S, Millar DS, Clark SJ, Rogers J, Handelsman DJ, Dong Q: Loss of annexin ii heavy and light chains in prostate cancer and its precursors. Cancer Res 2001, 61:6331-6334.
24. Vaarala MH, Porvari K, Kyllonen A, Vihko P: Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab Invest 2000, 80:1259-1268.
25. Drexler HG, Dirks WG, Matsuo Y, MacLeod RA: False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 2003, 17:416-426.
26. Pan Z, Shen Y, Du C, Zhou G, Rosenwald A, Staudt LM, Greiner TC, McKeithan TW, Chan WC: Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. Am J Pathol 2003, 163:135-144.
27. Chiang Y, Rizzino A, Sibenaller ZA, Wold MS, Vishwanatha JK: Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem 1999, 199:139-147.
28. Kumble KD, Vishwanatha JK: Immunoelectron microscopic analysis of the intracellular distribution of primer recognition proteins, annexin 2 and phosphoglycerate kinase, in normal and transformed cells. Journal of Cell Science 1991, 99:751-758.
29. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975, 98:503-517.
30. Seemann J, Weber K, Osborn M, Parton RG, Gerke V: The association of annexin I with early endosomes is regulated by Ca2+ and requires an intact N-terminal domain. Mol Biol Cell 1996, 7:1359-74.
31. Kuppers R, Zhao M, Hansmann ML, Rajewsky K: Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993, 12:4955-4967.
32. Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L, Chaganti RS, Klein U, Kuppers R, Rajewsky K, Dalla-Favera R: BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A 1998, 95:11816-11821.
33. Solito E, de Coupade C, Parente L, Flower RJ, Russo-Marie F: Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ 1998, 9:327-336.